MGMT and neoplasm: As shown in the public cohorts, MGMT‐silenced cases had a trend toward longer OS (71.3 vs. 28.1 months, p = 0.208, Figure 3c), which resulted significant in a multivariable analysis including patients' and tumor characteristics (Figure 3d).